Indication
Haemophilia
1 clinical trial
1 product
Clinical trial
Open-label Study Investigating Efficacy, Safety and Pharmacokinetics of Concizumab Prophylaxis in Children Below 12 Years With Haemophilia A or B With or Without InhibitorsStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Concizumab